AU2001276392A1 - Vaccine comprising a lung tumour associated antigen - Google Patents
Vaccine comprising a lung tumour associated antigenInfo
- Publication number
- AU2001276392A1 AU2001276392A1 AU2001276392A AU7639201A AU2001276392A1 AU 2001276392 A1 AU2001276392 A1 AU 2001276392A1 AU 2001276392 A AU2001276392 A AU 2001276392A AU 7639201 A AU7639201 A AU 7639201A AU 2001276392 A1 AU2001276392 A1 AU 2001276392A1
- Authority
- AU
- Australia
- Prior art keywords
- vaccine
- associated antigen
- tumour associated
- lung tumour
- lung
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 208000037841 lung tumor Diseases 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Marine Sciences & Fisheries (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0017512 | 2000-07-17 | ||
GBGB0017512.5A GB0017512D0 (en) | 2000-07-17 | 2000-07-17 | Novel compounds |
PCT/EP2001/007967 WO2002006338A1 (fr) | 2000-07-17 | 2001-07-11 | Vaccin comprenant un antigene associe a une tumeur du poumon |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001276392A1 true AU2001276392A1 (en) | 2002-01-30 |
Family
ID=9895804
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001276392A Abandoned AU2001276392A1 (en) | 2000-07-17 | 2001-07-11 | Vaccine comprising a lung tumour associated antigen |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2001276392A1 (fr) |
GB (1) | GB0017512D0 (fr) |
WO (1) | WO2002006338A1 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201319446D0 (en) * | 2013-11-04 | 2013-12-18 | Immatics Biotechnologies Gmbh | Personalized immunotherapy against several neuronal and brain tumors |
GB201520550D0 (en) | 2015-11-23 | 2016-01-06 | Immunocore Ltd & Adaptimmune Ltd | Peptides |
GB201520568D0 (en) | 2015-11-23 | 2016-01-06 | Immunocore Ltd | Peptides |
GB201520592D0 (en) * | 2015-11-23 | 2016-01-06 | Immunocore Ltd & Adaptimmune Ltd | Peptides |
NZ754139A (en) * | 2017-01-27 | 2022-07-01 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers |
CN111263768B (zh) * | 2017-07-25 | 2023-10-13 | Idp研发制药有限公司 | 抗癌肽 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6087168A (en) * | 1999-01-20 | 2000-07-11 | Cedars Sinai Medical Center | Conversion of non-neuronal cells into neurons: transdifferentiation of epidermal cells |
-
2000
- 2000-07-17 GB GBGB0017512.5A patent/GB0017512D0/en not_active Ceased
-
2001
- 2001-07-11 AU AU2001276392A patent/AU2001276392A1/en not_active Abandoned
- 2001-07-11 WO PCT/EP2001/007967 patent/WO2002006338A1/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2002006338A1 (fr) | 2002-01-24 |
GB0017512D0 (en) | 2000-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002336760A1 (en) | Mutable vaccines | |
GB0020953D0 (en) | Vaccine | |
HUP0301043A3 (en) | Vaccine | |
AU1591402A (en) | Vaccine | |
AU2001290860A1 (en) | Spas-1 cancer antigen | |
AU2002349543A1 (en) | Tumor antigens | |
GB0014288D0 (en) | Vaccine | |
AU2003289603A1 (en) | Tumor vaccine | |
AU2001276392A1 (en) | Vaccine comprising a lung tumour associated antigen | |
AU2002249823A1 (en) | Acne vaccine | |
EP1454914A4 (fr) | Antigene de tumeur | |
GB0026334D0 (en) | Vaccine | |
GB0014845D0 (en) | Vaccine | |
EP1403283A4 (fr) | Antigenes tumoraux | |
GB0025694D0 (en) | Vaccine | |
AU2002321882A1 (en) | Multivalent synthetic vaccine for cancer | |
AU2002303093A1 (en) | Mycobacterial vaccines | |
GB0003082D0 (en) | Vaccine | |
AU2001266534A1 (en) | Papillomavirus vaccine | |
AU3397101A (en) | Adjuvants | |
AUPQ865200A0 (en) | Haemagglutinin antigen | |
AU5084300A (en) | New vaccine formulations - 1 | |
GB0006693D0 (en) | Vaccine | |
GB0015722D0 (en) | Vaccine | |
AU2002238396A1 (en) | Tumor vaccine |